ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 164970 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 164970; 2) Community: the network communities that were significantly associated with the response to NSC 164970; 3) Molecule: the relationships between components within communities and NSC 164970; 4) MDR: the compounds that were significantly associated with the NSC 164970.

NSC Compound Enrichment Correlation
NSC 57958 Null 0.0267520285931239 0.10458905
NSC 618296 Null 0.0267520285931239 0.33719705
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0267520285931239 0.44677621
NSC 629749 .beta.-Lapachone 0.0267520285931239 0.4309938
NSC 634761 Cis-dibromocarbonylacetonitrile-bis-(triphenylphosphine) osmium(II) 0.0267520285931239 0.24028748
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0267520285931239 0.027912754
NSC 648365 Insulin-Methotrexate conjugate 0.0267520285931239 0.26055548
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0267520285931239 0.42888967
NSC 651774 Null 0.0267520285931239 0.43126577
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.0267520285931239 0.30878295
Total:96  Current:62    [First] [Prev] [Next] [Last]